Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

NCT03520517

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +13 more
Locations
  • Holy Cross Neuroscience Research Institute Fort Lauderdale, Florida, United States
  • Somnos/Neurology Associates Clinical Research Lincoln, Nebraska, United States
  • Neurosciences Institute, Neurology - Charlotte Charlotte, North Carolina, United States
  • Wesley Neurology Clinic Cordova, Tennessee, United States
View Trial Details
Completed

Genomic Translation for Amyotrophic Lateral Sclerosis Care

NCT02795897

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +10 more
Locations
  • Cedar Sinai Medical Center Los Angeles, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
  • Univeristy of Michigan Ann Arbor, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View all 14 locations
View Trial Details

Related conditions